Literature DB >> 18039809

Biotransformation of lithocholic acid by rat hepatic microsomes: metabolite analysis by liquid chromatography/mass spectrometry.

Anand K Deo1, Stelvio M Bandiera.   

Abstract

Lithocholic acid is a lipid-soluble hepatotoxic bile acid that accumulates in the liver during cholestasis. A potential detoxification pathway for lithocholic acid involves hydroxylation by hepatic cytochrome P450 (P450) enzymes. The purpose of the present study was to identify the hepatic microsomal metabolites of lithocholic acid by liquid chromatography/mass spectrometry and to determine the P450 enzymes involved. Incubation of lithocholic acid with rat hepatic microsomes and NADPH produced murideoxycholic acid (MDCA), isolithocholic acid (ILCA), and 3-keto-5beta-cholanic acid (3KCA) as major metabolites and 6-ketolithocholic acid and ursodeoxycholic acid as minor metabolites. Experiments with hepatic microsomes prepared from rats pretreated with P450 inducers and with inhibitory antibodies indicated that CYP2C and CYP3A enzymes contribute to microsomal MDCA formation. Results obtained with a panel of recombinant P450 enzymes and CYP2D6 antiserum showed that CYP2D1 can also catalyze MDCA formation. Similar experimental evidence revealed that formation of 3KCA was mediated primarily by CYP3A enzymes. ILCA formation appeared to be catalyzed by a distinct pathway mediated largely by microsomal non-P450 enzymes. Based on the results obtained using lithocholic acid and 3KCA as substrates, a mechanism for the formation of ILCA involving a geminal diol intermediate is outlined. In conclusion, lithocholic acid was extensively metabolized by multiple P450 enzymes with the predominant biotransformation pathway being hydroxylation at the 6beta-position. This study provides an insight into possible routes of detoxification of lithocholic acid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039809     DOI: 10.1124/dmd.107.017533

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice.

Authors:  Youcai Zhang; Curtis D Klaassen
Journal:  J Lipid Res       Date:  2010-07-29       Impact factor: 5.922

2.  Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice.

Authors:  Eugene Hrycay; Dana Forrest; Lin Liu; Renxue Wang; Jenny Tai; Anand Deo; Victor Ling; Stelvio Bandiera
Journal:  Mol Cell Biochem       Date:  2014-01-08       Impact factor: 3.396

Review 3.  Bile acids, obesity, and the metabolic syndrome.

Authors:  Huijuan Ma; Mary Elizabeth Patti
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-07-11       Impact factor: 3.043

Review 4.  Translational biomarkers of acetaminophen-induced acute liver injury.

Authors:  Richard D Beger; Sudeepa Bhattacharyya; Xi Yang; Pritmohinder S Gill; Laura K Schnackenberg; Jinchun Sun; Laura P James
Journal:  Arch Toxicol       Date:  2015-05-17       Impact factor: 5.153

Review 5.  The Effect of Lithocholic Acid on the Gut-Liver Axis.

Authors:  Wei Sheng; Guang Ji; Li Zhang
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

6.  Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph-Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice.

Authors:  Francesca Ferlenghi; Carmine Giorgio; Matteo Incerti; Lorenzo Guidetti; Paola Chiodelli; Marco Rusnati; Massimiliano Tognolini; Federica Vacondio; Marco Mor; Alessio Lodola
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-28

7.  Hyocholic acid and glycemic regulation: comments on 'Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism'.

Authors:  Wei Jia; Cynthia Rajani; Xiaojiao Zheng; Weiping Jia
Journal:  J Mol Cell Biol       Date:  2021-09-11       Impact factor: 6.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.